A combination of ergonomics, technology-based solutions and handson pain relief therapy has proven effective in reducing CTS risk and its associated costs. CTS accounts for more than $2 billion in economic costs each year from nearly 2 million annual cases, and for thousands of U.S. workers, it can lead to lifelong pain and loss of function even after surgery (Palmer & Hanrahan, 2019). Kevin Lombardo, president and CEO of DORN Co., is a widely recognized thought leader with experience in strategic planning, negotiating, structuring and conducting e?ective due diligence examinations for operational excellence in support of organizational scale, development of strategic partnerships and client expansion. Lombardo leads the strategy development and expansion plans for the company and oversees DORN's focus on developing innovative solutions for pain mitigation, with an emphasis on reducing organizations' future costs with evidence based, result-oriented programs.
